Transaction · 0001193125-26-403355

Jarrett Jennifer

Jarrett Jennifer, DIR, PRES, reported an open-market or private purchase at Damora Therapeutics, Inc. involving 12500.000000 shares for an estimated $252875.00. Reported holdings after the transaction were 512500.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

Open-market buySEC transaction code PDIR, PRES
DMRADamora Therapeutics, Inc.
Filing timeSep 28
Trade dateSep 25, 2026
Filing · SECView on SEC
InsiderProfile
% of reported position traded2.5%Shares purchased ÷ (holdings after − shares purchased). Estimated position before: 500,000 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
—
Pre-filing
1mo ago1w ago1d ago
Returns since
7d30d90d180d1y

DMRA price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
DMRA since 2026-09-28Filed today · pre-filing context shaded
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
Buy
Code P
Identifier
0001193125-26-403355
Ordinary Shares
Transaction date
Sep 25, 2026
Filed Sep 28, 2026, 11:00 AM · 3d delay
Shares
12.5k sh
$20.23 per share
Estimated value
$252k
Computed from shares × price
Holdings after
512k sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Director Buy Direct Ownership
+24score
Filing-only score

+24

Compact filing score computed from stored Form 4 facts. Version v1.

Positive filing signal

This filing has a modest positive filing-only score. Treat it as a useful flag for review, not as a buy signal.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

Director, President and CEO

Officer YesDirector Yes10% NoOther No
Footnotes & amended
  1. F1

    Represents shares purchased on the open market at prevailing market prices using personal funds.

  2. F2

    The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $20.10 to $20.40, inclusive. The Reporting Person undertakes to…

  3. F3

    Includes 500,000 restricted stock units ("RSUs") previously granted to the Reporting Person. Each RSU represents the right to receive, at settlement, one ordinary share of the Issuer.

Original filing · 0001193125-26-403355
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

DMRA